Gabrielle Lê-Bury

Gabrielle Lê-Bury

Auto-generated profile, based on publicly available information

Gabrielle Lê-Bury

Université Paris Cité, Institut Cochin, INSERM, CNRS, F-75014 Paris, France

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
DPDavide Pisu
Davide Pisu
LHLu Huang
Lu Huang
VNVipin Narang
Vipin Narang
MTMonique Theriault
Monique Theriault
GLGabrielle Lê-Bury
Gabrielle Lê-Bury
DRDavid Russell
David Russell
In this study, we detail a novel approach that combines bacterial fitness fluorescent reporter strains with scRNA-seq to simultaneously acquire the host transcriptome, surface marker expression, and bacterial phenotype for each infected cell. This approach facilitates the dissection of the functional heterogeneity of M. tuberculosis–infected alveolar (AMs) and interstitial macrophages (IMs) in vivo. We identify clusters of pro-inflammatory AMs associated with stressed bacteria, in addition to three different populations of IMs with heterogeneous bacterial phenotypes. Finally, we show that the main macrophage populations in the lung are epigenetically constrained in their response to infection, while inter-species comparison reveals that most AMs subsets are conserved between mice and humans. This conceptual approach is readily transferable to other infectious disease agents with the potential for an increased understanding of the roles that different host cell populations play during the course of an infection.

9 July 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
MTMonique E. Theriault
Monique E. Theriault
DPDavide Pisu
Davide Pisu
KWKaley M. Wilburn
Kaley M. Wilburn
GLGabrielle Lê-Bury
Gabrielle Lê-Bury
CMCase W. McNamara
Case W. McNamara
DRDavid Russell
David Russell
Mycobacterium tuberculosis (Mtb), the cause of the human pulmonary disease tuberculosis (TB), contributes to approximately 1.5 million deaths every year. Prior work has established that lipids are actively catabolized by Mtb in vivo and fulfill major roles in Mtb physiology and pathogenesis. We conducted a high-throughput screen to identify inhibitors of Mtb survival in its host macrophage. One of the hit compounds identified in this screen, sAEL057, demonstrates highest activity on Mtb growth in conditions where cholesterol was the primary carbon source. Transcriptional and functional data indicate that sAEL057 limits Mtb’s access to iron by acting as an iron chelator. Furthermore, pharmacological and genetic inhibition of iron acquisition results in dysregulation of cholesterol catabolism, revealing a previously unappreciated linkage between these pathways. Characterization of sAEL057’s mode of action argues that Mtb’s metabolic regulation reveals vulnerabilities in those pathways that impact central carbon metabolism.

13 May 2026 in mBio
Verified
Journal Article
Open access
MTMonique E. Theriault
Monique E. Theriault
AWAndrew I. Wong
Andrew I. Wong
MDMichael A. DeJesus
Michael A. DeJesus
DPDavide Pisu
Davide Pisu
BLBom Nae Rin Lee
Bom Nae Rin Lee
JRJeremy M. Rock
Jeremy M. Rock
Mycobacterium tuberculosis (Mtb) remains a leading cause of infectious disease mortality worldwide, largely due to its ability to survive within host macrophages. Despite advances in understanding the environmental pressures Mtb encounters in vivo , the genetic requirements for adaptation and survival within the intracellular niche remain incompletely defined. Here, we employed a genome-wide CRISPR interference (CRISPRi) screen in an ex vivo model exploiting single-cell suspensions from Mtb-infected mouse lung homogenates to identify genes critical for intracellular survival at different time points in the infection continuum. Using a library comprising ~20,000 sgRNAs covering >96% of Mtb open reading frames, we identified genes required for growth within the changing immune microenvironment. Mutant depletion patterns varied across immune environments sampled at 2, 4, and 6 weeks post-infection, which revealed a weighted dependency on cell wall biosynthesis genes early and the reliance on cholesterol catabolism and iron acquisition across all time points. Functional validation of three genes— embB , fadE29 , and mbtI —confirmed their temporal significance in vivo . This screen provides increased resolution of the differential metabolic vulnerabilities in Mtb in the evolving immune environments during infection, stressing the temporal nature of conditional essentiality in vivo . IMPORTANCE: Mycobacterium tuberculosis (Mtb) remains a leading cause of infectious disease mortality worldwide, largely due to its ability to survive within host macrophages. Despite advances in understanding the environmental pressures Mtb encounters in vivo , the genetic requirements for adaptation and survival within the intracellular niche remain incompletely defined. Here, we employed a genome-wide CRISPR interference (CRISPRi) screen in an ex vivo model exploiting single-cell suspensions from Mtb-infected mouse lung homogenates to identify genes critical for intracellular survival at different time points in the infection continuum. This novel approach enabled us to identify how different bacterial metabolic pathways were of greater importance to the bacterium at different time points post-infection. The results provide insights into how the evolving immune response to infection shapes the metabolic and replicative status of the bacterium. This information has significance in the design of therapeutic strategies toward cure.

19 December 2023 in mBio
Verified
Journal Article
Open access
GLGabrielle Lê-Bury
Gabrielle Lê-Bury
YCYao Chen
Yao Chen
JRJordan M. Rhen
Jordan M. Rhen
JGJennifer K. Grenier
Jennifer K. Grenier
ASAmit Singhal
Amit Singhal
SBSaikat Boliar
Saikat Boliar
HIV-1 latency is a multi-dimensional, dynamic process, and many aspects of how the viral latency is established and maintained remain incompletely characterized. We have investigated how the host cellular epigenomic and transcriptomic microenvironments compare depending on the transcriptional state of the virus. Using a dual-reporter HIV GKO virus, we identified a significant divergence in chromatin reorganization and cellular gene expression patterns between active and latent HIV-1 infections of SupT1 cells. Latent HIV-1 infection induced significantly more cellular epigenomic restructuring than active infection. Furthermore, the nature of epigenomic changes also differed between the two states of HIV-1 infection. The majority of the changes in latent HIV-1 infection were repressive, whereas active viral infection led to an overall increase in chromatin accessibility. The repressed chromatin remodeling in latent infection was associated with the downregulation of genes involved in DNA replication, DNA repair, and cell cycle pathways, whereas the open chromatin structure in active infection led to increased expression of genes enriched for lipid metabolism, vesicle, and small molecule transport pathways. Similar to cellular mRNAs, our comprehensive transcriptomic analysis also identified a significant shift in long non-coding RNA (lncRNA) epigenomic and expression profiles between active and latent HIV-1 infections. Putative functional roles of novel lncRNAs associated with cellular pathways dysregulated in active and latent HIV-1 infections were identified, and the effects of viral reactivation on lncRNA expression in latently infected cells were evaluated. This study revealed that HIV-1 latent infection necessitates substantially greater alterations in the cellular epigenome and transcriptome than active HIV-1 infection. IMPORTANCE: HIV-1 infection of T-lymphocytes depends on co-opting cellular transcriptional and translational machineries for viral replication. This requires significant changes in the cellular microenvironment. We have characterized and compared the changes in cellular chromatin structures as well as gene expression landscapes in T cells that are either actively or latently infected with HIV-1. Our results reveal that chromatin accessibility and expression of both protein-coding mRNAs and non-coding lncRNAs are uniquely regulated in HIV-1-infected T cells, depending on whether the virus is actively transcribing or remains in a transcriptionally silent, latent state. HIV-1 latent infection elicits more robust changes in the cellular chromatin organization than active viral infection. Our analysis also identifies the effects of such epigenomic changes on the cellular gene expression and subsequent biological pathways. This study comprehensively characterizes the cellular epigenomic and transcriptomic states that support active and latent HIV-1 infection in an in vitro model of SupT1 cells.

6 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
FHF Herit
F Herit
GLG Lê-Bury
G Lê-Bury
QPQ Provôt
Q Provôt
DTD To-Puzenat
D To-Puzenat
JHJ Haagen
J Haagen
FNF Niedergang
F Niedergang
HIV-1 (Human Immunodeficiency Virus type 1) infects macrophages, which resist to the cytopathic effects of the virus and are considered as viral reservoirs. However, the cellular factors involved in viral production by human macrophages have not been fully identified. In this study, we focused on the amino acid transporter SNAT7 (small neutral amino-acid transporter 7), member of the SLC38 solute carrier family, which is the main lysosomal transporter of glutamine from the lysosome to the cytoplasm. Its expression was increased by HIV-1 infection. We revealed that the absence of SNAT7 inhibited viral production not only at the level of protein synthesis, but also early at the level of reverse transcription, without affecting global RNA or protein synthesis in the cells. The reduction in HIV expression upon SNAT7 depletion correlated with a reduction in the levels of an inactive form of the SAMHD1 (SAM domain- and HD domain-containing protein) restriction factor and was rescued following SAMHD1 degradation. Lastly, supplementation of the extracellular medium with glutamine in the absence of SNAT7 partially restored viral production. Together, our data reveal that glutamine extracted from lysosomes is involved in the early stages of the HIV-1 cycle and that the SNAT7 glutamine transporter acts as a dependency factor for HIV-1 in human macrophages.

2 April 2026
Verified
Thesis
Closed access
GLGabrielle Lê-Bury
Gabrielle Lê-Bury
Le Virus de l'Immunodéficience Humaine de type 1 (VIH-1) infecte les macrophages. Contrairement aux lymphocytes T CD4+, les macrophages résistent aux effets cytotoxiques du virus et représentent un réservoir pour ce pathogène. Dans ces cellules, le virus est produit et stocké dans un compartiment intracellulaire spécifique appelé VCC (Virus-Containing Compartment). Ce compartiment à pH neutre, transitoirement connecté à la membrane plasmique, reste cependant très peu caractérisé. Par ailleurs, le VIH-1 induit une perturbation des fonctions des macrophages, permettant ainsi le développement de bactéries opportunistes, telles que des souches particulières de Salmonella Typhimurium. Nous avons étudié en particulier des souches de Salmonella Typhimurium invasives non typhiques qui se sont développées, chez des patients séropositifs. Les objectifs de ma thèse ont donc été d'étudier, dans les macrophages primaires humains, les facteurs moléculaires impliqués dans la production du VIH-1 et le développement de souches invasives de Salmonella Typhimurium. Dans un premier temps, j'ai contribué à étudier les effets de l'infection par le VIH-1 sur les fonctions des macrophages. Leur fonction majeure est la phagocytose qui est un mécanisme de défense contre les pathogènes permettant leur internalisation et leur dégradation. Il avait déjà été montré au laboratoire que l'étape d'internalisation était en partie inhibée par le facteur de virulence Nef dans les macrophages infectés. Dans ce travail, nous avons montré que l'infection de ces cellules par le VIH-1 inhibe également la maturation des phagosomes, mais via la protéine virale Vpr. Nous avons aussi mis en évidence que le VIH-1 conduit le macrophage dans en état de pré-activation, mais empêche la cellule de répondre à un stimulus ultérieur comme une surinfection bactérienne. Dans un second temps, j'ai participé à l'étude des coinfections entre VIH-1 et les bactéries Salmonella Typhimurium invasives, qui ont émergé avec l'infection par le virus, en comparaison avec des souches de référence. Ce travail nous a permis de montrer que les bactéries, pour leur survie, n'exploitent pas le compartiment viral dans les macrophages co-infectés. J'ai ensuite observé que la souche invasive de Salmonella Typhimurium induit moins de mort cellulaire par pyroptose qu'une souche de référence. J'ai alors déterminé les voies de signalisation en amont de cette mort cellulaire qui est associée à un mécanisme inflammatoire. Ainsi, j'ai mis en évidence que la souche invasive de Salmonella détourne les mécanismes de pyroptose et survit mieux dans les macrophages, ce qui pourrait expliquer la dissémination observée chez les patients. Enfin, j'ai initié l'étude de nouveaux facteurs cellulaires impliqués dans la production virale par les macrophages. À la suite d'une analyse transcriptomique sur des macrophages primaires humains infectés ou non par le VIH-1, nous avons identifié un nombre important de transporteurs membranaires appelés SLC (Solute Carrier) dont l'expression est modulée par l'infection. Après la sélection de candidats, j'ai pu mettre en évidence que certains de ces SLC étaient importants pour la production virale par les macrophages. En conclusion, l'ensemble de ces travaux contribue à définir comment le VIH-1 infecte les macrophages et diminue leurs fonctions d'activation et de clairance, et comment se développent des bactéries opportunistes pathogènes.